Peptide Lab HQ Research Guide
Vilon
A research-focused compound profile covering Vilon identity, Lys-Glu dipeptide research, peptide bioregulator models, immune-cell signaling research, chromatin activity context, concentration reference, reconstitution reference, and safety considerations.
Compound Data
Compound Profile
| Compound Name | Vilon |
|---|---|
| Common Research Name | Lys-Glu dipeptide / KE peptide |
| Common Synonyms | Lys-Glu, L-Lys-L-Glu, lysylglutamic acid, H-Lys-Glu-OH, peptide Vilon |
| Compound Type | Synthetic ultrashort dipeptide / peptide bioregulator research compound |
| CAS Number | 45234-02-4; verify against supplier COA |
| PubChem CID | 7010502 |
| Amino Acid Length | 2 amino acids |
| Amino Acid Sequence | Lys-Glu |
| Short Sequence | KE |
| Molecular Formula | C₁₁H₂₁N₃O₅; verify against supplier COA |
| Molecular Weight | Approximately 275.30 g/mol; verify against supplier COA |
| Research Category | Peptide bioregulator, immune-cell signaling, IL-2 gene-expression research, chromatin activity, lymphocyte research, intestinal enzyme activity, and aging-marker research |
| Research Context | Commonly discussed in ultrashort peptide bioregulator research involving immune-cell response, interleukin-2 expression, chromatin deheterochromatinization, digestive enzyme activity, and aging-associated cellular models. |
| Appearance | White to off-white lyophilized powder, depending on supplier documentation |
| Use | For laboratory research use only. |
Research Applications
Key Research Applications
Vilon is commonly discussed in controlled research models involving Lys-Glu dipeptide activity, peptide bioregulation, immune-cell signaling, interleukin-2 gene-expression context, chromatin activity, lymphocyte aging models, digestive enzyme activity, and intestinal transport research.
Peptide Bioregulator Research
Vilon is commonly positioned within ultrashort peptide bioregulator research, where short amino acid sequences are studied for tissue-specific signaling and gene-expression related effects.
Immune-Cell Signaling Models
Vilon has been studied in immune-cell research involving lymphocytes, splenocytes, thymocyte-associated contexts, and immune-response marker expression.
IL-2 Gene-Expression Research
Lys-Glu / Vilon appears in research involving interleukin-2 mRNA synthesis and gene-expression response in immune-cell models.
Chromatin Activity Context
Vilon has been discussed in chromatin research involving deheterochromatinization, lymphocyte aging models, and age-associated transcriptional activity.
Digestive Enzyme Research
Vilon has appeared in aged-rat research involving small-intestinal enzyme activity, nutrient transport characteristics, and gastrointestinal tissue-response observations.
Aging-Marker Research
Short peptide bioregulator research commonly evaluates cellular aging markers, chromatin state, immune-cell function, enzyme activity, and tissue-response documentation.
Research Scope
These applications are provided for educational and research-reference purposes only. Vilon research is limited compared with major peptide categories, and outcomes may vary based on peptide identity, purity, study model, concentration, exposure duration, tissue model, and laboratory conditions.
Reference Only
Reconstitution / Research Dosing Reference
Quick Reference Summary
| Reference Vial | 20 mg Vilon |
|---|---|
| Primary Solution Volume | 1.0 mL bacteriostatic water |
| Primary Concentration | 20 mg/mL |
| Measurement Reference | On a U-100 syringe, 1 unit = 0.01 mL. |
| Amount per U-100 Unit | At 20 mg/mL, 1 unit equals 0.2 mg / 200 mcg Vilon. |
| Storage Reference | Refrigerate at 2–8°C / 35.6–46.4°F after reconstitution, protected from direct light. |
Reconstitution Steps
- Draw 1.0 mL bacteriostatic water using a sterile syringe for the main concentration reference shown below.
- Slowly add the BAC water down the side of the vial wall.
- Gently roll or swirl the vial until the material is completely dissolved. The solution should appear clear to slightly hazy depending on concentration and supplier format. Do not shake!
- Because this is a concentrated 20 mg/mL preparation, verify complete dissolution before recording final preparation details.
- Label with compound name, vial amount, concentration, solvent volume, preparation date, storage conditions, and handling notes.
- Store refrigerated at 2–8°C / 35.6–46.4°F, protected from direct light.
Published Research Context
| Reference Type | Reported Amount / Context | Research Notes |
|---|---|---|
| Compound Identity Reference | Vilon, commonly referenced as KE peptide / Lys-Glu | Vilon is commonly discussed as a synthetic dipeptide bioregulator composed of lysine and glutamic acid. |
| Peptide Bioregulator Research | Model-dependent concentration and endpoint tracking | Commonly discussed in short-peptide bioregulator, DNA / chromatin interaction, gene-expression, cellular-response, and regulatory peptide research contexts. |
| Immune / Inflammatory-Marker Research | Cellular and model-dependent context | Vilon-related research discussions commonly include immunomodulatory markers, inflammatory-marker response, proliferative-activity markers, and cellular regulation models. |
| Cellular-Aging Research Context | SIRT1 / PARP and gene-expression marker context | Research discussions commonly include SIRT1, PARP1, PARP2, DNA-repair-marker, cellular-aging, stress-response, and gene-expression pathway observations. |
| Proliferation / Oncostatic Research Context | Experimental and model-dependent context | Vilon has been discussed in relation to proliferative activity, cell-cycle marker observations, oncostatic research models, and age-associated cellular-response contexts. |
| Public Protocol-Style Reference | Milligram-range reference examples | Public protocol-style references commonly describe Vilon in milligram-range examples. These are not clinical dosing standards. |
| Clinical / Research-Chemical Status | No universal research-chemical protocol established | Published study references, public protocol-style references, clinical-use references, or wellness protocols should not be treated as dosing instructions for research-chemical vial formats. |
Concentration Reference
| Vial Amount | Solution Volume | Final Concentration |
|---|---|---|
| 20 mg | 1.0 mL | 20 mg/mL |
Research Dosing Amount / Volume Reference
| Reference Amount | Volume at 20 mg/mL | U-100 Unit Reference | Approx. References per 20 mg Vial |
|---|---|---|---|
| 0.5 mg / 500 mcg | 0.025 mL | 2.5 units | 40 |
| 1 mg / 1000 mcg | 0.05 mL | 5 units | 20 |
| 2 mg / 2000 mcg | 0.10 mL | 10 units | 10 |
| 5 mg / 5000 mcg | 0.25 mL | 25 units | 4 |
| 10 mg / 10000 mcg | 0.50 mL | 50 units | 2 |
| 20 mg / 20000 mcg | 1.00 mL | 100 units | 1 |
Research Frequency / Amount Reference
| Research Window | Frequency | Reference Amount | Units / Volume Reference |
|---|---|---|---|
| Lower Conversion Reference | Public protocol-style reference, not a clinical dosing standard | 0.5 mg reference amount | 2.5 units / 0.025 mL |
| Standard Conversion Reference | Public protocol-style reference, not a clinical dosing standard | 1 mg reference amount | 5 units / 0.05 mL |
| Mid-Range Conversion Example | Calculation reference only | 2 mg reference amount | 10 units / 0.10 mL |
| Upper Conversion Example | Calculation reference only | 5 mg reference amount | 25 units / 0.25 mL |
| High Conversion Example | Calculation reference only | 10 mg reference amount | 50 units / 0.50 mL |
| Full-Vial Preparation Reference | Preparation-level calculation reference | 20 mg reference amount | 100 units / 1.00 mL |
Common Research Windows
| Reference Window | Common Length | Research Notes |
|---|---|---|
| Cell-Culture / Gene-Expression Window | 24–72 hours | May be used for gene-expression, SIRT1 / PARP marker, DNA-repair marker, inflammatory-marker, proliferative-activity, or peptide-response documentation depending on the model. |
| Acute Cellular Observation Window | Single session to several days | Used for early response tracking, inflammatory-marker comparison, cell-proliferation marker observation, or short-term pathway documentation depending on the research design. |
| Short Research Window | 1–2 weeks | May be used for short-duration controlled observation involving immune-marker, inflammatory-marker, cellular-aging, or gene-expression endpoints. |
| Standard Protocol-Style Window | 2–4 weeks | Commonly used in public protocol-style references for structured observation and comparison across baseline and follow-up periods. |
| Extended Observation Window | 4–8 weeks | Used when longer documentation is needed for gene-expression trends, cellular-aging context, inflammatory-marker comparison, or follow-up marker tracking. |
| Follow-Up / Washout | 1–4 weeks | Used to document post-study observations, marker return, delayed response patterns, or follow-up data depending on the research model. |
Research Note: These tables are provided for educational, research-planning, concentration, frequency-reference, and volume-reference purposes only. Vilon, commonly referenced as KE peptide / Lys-Glu, is discussed in peptide bioregulator, immune-marker, inflammatory-marker, proliferative-activity, SIRT1 / PARP, DNA-repair-marker, gene-expression, cellular-aging, and short-peptide regulatory research contexts. This reference uses a 20 mg vial reconstituted with 1.0 mL bacteriostatic water, creating a 20 mg/mL concentration. Higher-concentration preparations may require supplier-specific handling, solvent-volume, or solubility notes; verify against the COA, batch record, or formula record when available. Published study references and public protocol-style frequency references are not universal research-chemical dosing standards and should not be treated as dosing instructions for research-chemical vial formats. This information is not medical advice, dosing instruction, injectable-use guidance, or a recommendation for human or animal use.
Research Notes
Research Findings & Safety Notes
Research Findings
Vilon is commonly discussed in research involving Lys-Glu dipeptide signaling, ultrashort peptide bioregulation, immune-cell response, IL-2 gene-expression activity, chromatin deheterochromatinization, intestinal transport characteristics, digestive enzyme activity, and aging-associated cellular models.
Study Limitations
Vilon research is limited compared with major peptide categories and includes immune-cell, chromatin, intestinal, aging-marker, and peptide bioregulator references. Findings should be interpreted according to peptide identity, purity, study model, concentration, exposure duration, and endpoint selection.
Safety Considerations
Research discussion should account for peptide identity verification, KE sequence confirmation, sterility documentation, endotoxin risk, supplier qualification, batch records, storage conditions, route-specific uncertainty, and qualified laboratory handling procedures.
Use Restriction
Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease when discussed as a research-use material.
Related Supplies
Research Supplies
For research supplies, visit our affiliate partner and use code PLHQ10 to save 10% on your order.
Bacteriostatic Water
Commonly referenced in laboratory preparation workflows.
Research Syringes
Supply category for controlled laboratory research preparation.
Prep Supplies
Supporting supplies for clean handling, preparation, and documentation.
Lab Handling
Handling & Storage
Storage
Store materials according to product-specific requirements. Protect from excessive heat, moisture, and direct light.
After Reconstitution
Keep refrigerated after reconstitution unless otherwise specified by the product documentation.
Handling
Use appropriate laboratory PPE, clean handling practices, and qualified research procedures.
Documentation
Maintain batch details, COA records, preparation notes, and internal research documentation.